| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mesenchymal stem cells in health and disease.
|
Nat Rev Immunol
|
2008
|
11.14
|
|
2
|
Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.
|
J Exp Med
|
2002
|
4.32
|
|
3
|
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.
|
J Exp Med
|
2003
|
3.52
|
|
4
|
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.
|
Blood
|
2007
|
3.38
|
|
5
|
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.
|
Blood
|
2005
|
3.37
|
|
6
|
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
|
Cancer Res
|
2002
|
3.00
|
|
7
|
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.
|
J Immunol
|
2007
|
2.97
|
|
8
|
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells.
|
Proc Natl Acad Sci U S A
|
2003
|
2.71
|
|
9
|
Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs.
|
Proc Natl Acad Sci U S A
|
2004
|
2.66
|
|
10
|
Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.
|
Cancer Res
|
2012
|
2.54
|
|
11
|
Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.
|
Proc Natl Acad Sci U S A
|
2003
|
2.51
|
|
12
|
Mesenchymal stem cells: a new strategy for immunosuppression?
|
Trends Immunol
|
2007
|
2.50
|
|
13
|
Immunoregulatory function of mesenchymal stem cells.
|
Eur J Immunol
|
2006
|
2.47
|
|
14
|
MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.
|
Blood
|
2009
|
2.33
|
|
15
|
NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor.
|
Blood
|
2005
|
2.31
|
|
16
|
The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44).
|
Eur J Immunol
|
2003
|
2.29
|
|
17
|
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells.
|
Proc Natl Acad Sci U S A
|
2004
|
2.23
|
|
18
|
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112).
|
Blood
|
2004
|
2.17
|
|
19
|
What is a natural killer cell?
|
Nat Immunol
|
2002
|
2.11
|
|
20
|
NK cells: a lesson from mismatched hematopoietic transplantation.
|
Trends Immunol
|
2002
|
2.02
|
|
21
|
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.
|
Blood
|
2008
|
1.96
|
|
22
|
Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis.
|
Proc Natl Acad Sci U S A
|
2004
|
1.95
|
|
23
|
A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes.
|
Blood
|
2012
|
1.92
|
|
24
|
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.
|
Cancer Res
|
2004
|
1.87
|
|
25
|
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients.
|
Eur J Immunol
|
2007
|
1.86
|
|
26
|
Cellular ligands of activating NK receptors.
|
Trends Immunol
|
2005
|
1.84
|
|
27
|
The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity.
|
Structure
|
2003
|
1.82
|
|
28
|
Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease.
|
Blood
|
2006
|
1.82
|
|
29
|
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?
|
Blood
|
2011
|
1.78
|
|
30
|
Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation.
|
Proc Natl Acad Sci U S A
|
2010
|
1.74
|
|
31
|
A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2.
|
Blood
|
2010
|
1.67
|
|
32
|
Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
|
Cancer
|
2008
|
1.66
|
|
33
|
The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells.
|
Eur J Immunol
|
2003
|
1.60
|
|
34
|
Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction.
|
Blood
|
2005
|
1.57
|
|
35
|
Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.
|
Blood
|
2011
|
1.56
|
|
36
|
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
|
Eur J Immunol
|
2003
|
1.55
|
|
37
|
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients.
|
Eur J Immunol
|
2004
|
1.53
|
|
38
|
The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells.
|
Eur J Immunol
|
2004
|
1.50
|
|
39
|
Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations.
|
Blood
|
2002
|
1.49
|
|
40
|
Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.
|
Immunol Rev
|
2008
|
1.47
|
|
41
|
NK cells recognize and kill human glioblastoma cells with stem cell-like properties.
|
J Immunol
|
2009
|
1.46
|
|
42
|
Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells.
|
Eur J Immunol
|
2005
|
1.42
|
|
43
|
Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.
|
Stem Cells
|
2008
|
1.42
|
|
44
|
The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function.
|
Blood
|
2006
|
1.41
|
|
45
|
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation.
|
Proc Natl Acad Sci U S A
|
2002
|
1.40
|
|
46
|
Natural killer cells kill human melanoma cells with characteristics of cancer stem cells.
|
Int Immunol
|
2009
|
1.37
|
|
47
|
Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells.
|
Int Immunol
|
2008
|
1.36
|
|
48
|
Early liaisons between cells of the innate immune system in inflamed peripheral tissues.
|
Trends Immunol
|
2005
|
1.35
|
|
49
|
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors.
|
Eur J Immunol
|
2003
|
1.35
|
|
50
|
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity.
|
Proc Natl Acad Sci U S A
|
2009
|
1.34
|
|
51
|
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression.
|
Proc Natl Acad Sci U S A
|
2010
|
1.30
|
|
52
|
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes.
|
Proc Natl Acad Sci U S A
|
2010
|
1.28
|
|
53
|
HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes.
|
Proc Natl Acad Sci U S A
|
2003
|
1.27
|
|
54
|
The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils.
|
Blood
|
2005
|
1.26
|
|
55
|
Structural basis for a major histocompatibility complex class Ib-restricted T cell response.
|
Nat Immunol
|
2006
|
1.23
|
|
56
|
Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells.
|
Blood
|
2008
|
1.22
|
|
57
|
Membrane-bound and soluble IL-15/IL-15Ralpha complexes display differential signaling and functions on human hematopoietic progenitors.
|
Blood
|
2005
|
1.22
|
|
58
|
Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT.
|
Blood
|
2011
|
1.22
|
|
59
|
Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC.
|
Int Immunol
|
2008
|
1.20
|
|
60
|
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment.
|
Eur J Immunol
|
2011
|
1.19
|
|
61
|
Origin, phenotype and function of human natural killer cells in pregnancy.
|
Trends Immunol
|
2011
|
1.18
|
|
62
|
Cellular and molecular interactions of mesenchymal stem cells in innate immunity.
|
Immunol Cell Biol
|
2012
|
1.16
|
|
63
|
The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells.
|
J Immunol
|
2005
|
1.15
|
|
64
|
Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function.
|
Eur J Immunol
|
2008
|
1.15
|
|
65
|
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function.
|
Blood
|
2006
|
1.14
|
|
66
|
A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin.
|
Blood
|
2005
|
1.12
|
|
67
|
Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
|
J Immunol
|
2014
|
1.12
|
|
68
|
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors.
|
J Immunol
|
2005
|
1.11
|
|
69
|
Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses.
|
Blood
|
2006
|
1.11
|
|
70
|
PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.
|
Mol Immunol
|
2005
|
1.11
|
|
71
|
Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells.
|
Front Immunol
|
2013
|
1.10
|
|
72
|
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells.
|
Proc Natl Acad Sci U S A
|
2011
|
1.09
|
|
73
|
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells.
|
Blood
|
2002
|
1.08
|
|
74
|
Selective cross-talk among natural cytotoxicity receptors in human natural killer cells.
|
Eur J Immunol
|
2003
|
1.08
|
|
75
|
Effect of tumor cells and tumor microenvironment on NK-cell function.
|
Eur J Immunol
|
2014
|
1.08
|
|
76
|
Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function.
|
Eur J Immunol
|
2011
|
1.07
|
|
77
|
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation.
|
Proc Natl Acad Sci U S A
|
2013
|
1.07
|
|
78
|
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice.
|
Cancer Immunol Immunother
|
2007
|
1.07
|
|
79
|
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells.
|
Eur J Immunol
|
2004
|
1.05
|
|
80
|
Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis type 3.
|
J Med Genet
|
2011
|
1.05
|
|
81
|
Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells.
|
Blood
|
2007
|
1.05
|
|
82
|
The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.
|
J Biomed Biotechnol
|
2010
|
1.05
|
|
83
|
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction.
|
Blood
|
2009
|
1.05
|
|
84
|
Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference.
|
Clin Immunol
|
2009
|
1.04
|
|
85
|
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph.
|
J Immunol
|
2014
|
1.04
|
|
86
|
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor.
|
Eur J Immunol
|
2012
|
1.03
|
|
87
|
Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
|
Arthritis Rheum
|
2010
|
1.03
|
|
88
|
Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cells.
|
Cancer Lett
|
2008
|
1.02
|
|
89
|
Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion.
|
Eur J Immunol
|
2005
|
1.02
|
|
90
|
Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining.
|
J Immunol
|
2010
|
1.00
|
|
91
|
Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors.
|
Curr Opin Immunol
|
2005
|
1.00
|
|
92
|
Neuroblastoma-derived TGF-β1 modulates the chemokine receptor repertoire of human resting NK cells.
|
J Immunol
|
2013
|
1.00
|
|
93
|
The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity.
|
Eur J Immunol
|
2004
|
0.99
|
|
94
|
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response.
|
PLoS One
|
2012
|
0.99
|
|
95
|
Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.
|
Proc Natl Acad Sci U S A
|
2002
|
0.98
|
|
96
|
Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function.
|
Cytometry A
|
2013
|
0.98
|
|
97
|
Perturbations of natural killer cell regulatory functions in respiratory allergic diseases.
|
J Allergy Clin Immunol
|
2007
|
0.98
|
|
98
|
Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells.
|
Mol Immunol
|
2004
|
0.97
|
|
99
|
Human NK Cells induce neutrophil apoptosis via an NKp46- and Fas-dependent mechanism.
|
J Immunol
|
2012
|
0.97
|
|
100
|
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages.
|
Eur J Immunol
|
2012
|
0.97
|
|
101
|
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment.
|
Int Immunol
|
2009
|
0.96
|
|
102
|
Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function.
|
Immunology
|
2004
|
0.95
|
|
103
|
CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection.
|
Eur J Immunol
|
2010
|
0.95
|
|
104
|
Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.
|
J Biol Chem
|
2013
|
0.95
|
|
105
|
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation.
|
Eur J Immunol
|
2013
|
0.94
|
|
106
|
Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor.
|
Blood
|
2012
|
0.93
|
|
107
|
Familial hemophagocytic lymphohistiocytosis may present during adulthood: clinical and genetic features of a small series.
|
PLoS One
|
2012
|
0.93
|
|
108
|
Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection.
|
J Immunol
|
2005
|
0.93
|
|
109
|
At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.
|
J Leukoc Biol
|
2013
|
0.92
|
|
110
|
Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells.
|
Eur J Immunol
|
2006
|
0.91
|
|
111
|
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity.
|
Eur J Immunol
|
2003
|
0.91
|
|
112
|
NK cell function in HIV-1 infection.
|
Curr HIV Res
|
2008
|
0.91
|
|
113
|
HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.
|
Curr Pharm Des
|
2009
|
0.90
|
|
114
|
Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice.
|
Cancer Res
|
2004
|
0.90
|
|
115
|
HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
|
Hum Immunol
|
2004
|
0.90
|
|
116
|
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients.
|
AIDS
|
2003
|
0.90
|
|
117
|
Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15.
|
PLoS One
|
2008
|
0.90
|
|
118
|
Human congenital infection with Trypanosoma cruzi induces phenotypic and functional modifications of cord blood NK cells.
|
Pediatr Res
|
2006
|
0.90
|
|
119
|
Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation.
|
Eur J Immunol
|
2004
|
0.90
|
|
120
|
Natural killer cells in human pregnancy.
|
J Reprod Immunol
|
2013
|
0.90
|
|
121
|
Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells.
|
PLoS One
|
2009
|
0.89
|
|
122
|
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency.
|
Blood
|
2007
|
0.89
|
|
123
|
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors.
|
Int Immunol
|
2007
|
0.87
|
|
124
|
Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC.
|
Eur J Immunol
|
2013
|
0.87
|
|
125
|
Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation.
|
Immunol Lett
|
2013
|
0.87
|
|
126
|
Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perforin expression.
|
Br J Haematol
|
2002
|
0.87
|
|
127
|
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts.
|
Blood
|
2013
|
0.86
|
|
128
|
Human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation: analysis of the surface expression and function of activating NK receptors.
|
Mol Immunol
|
2005
|
0.86
|
|
129
|
Differential NKp30 inducibility in chimpanzee NK cells and conserved NK cell phenotype and function in long-term HIV-1-infected animals.
|
J Immunol
|
2007
|
0.85
|
|
130
|
Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity.
|
Eur J Immunol
|
2007
|
0.85
|
|
131
|
Characterization of human afferent lymph dendritic cells from seroma fluids.
|
J Immunol
|
2013
|
0.85
|
|
132
|
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.
|
Int Immunol
|
2009
|
0.85
|
|
133
|
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.
|
Haematologica
|
2013
|
0.85
|
|
134
|
Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products.
|
Trends Immunol
|
2010
|
0.84
|
|
135
|
Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells.
|
Int Immunol
|
2008
|
0.84
|
|
136
|
2B4 (CD244) is expressed and functional on human eosinophils.
|
J Immunol
|
2005
|
0.84
|
|
137
|
NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption.
|
Int Immunol
|
2011
|
0.84
|
|
138
|
Melanoma immunoediting by NK cells.
|
Oncoimmunology
|
2012
|
0.84
|
|
139
|
Multiple relapses of visceral leishmaniasis in an adolescent with idiopathic CD4+ lymphocytopenia associated with novel immunophenotypic and molecular features.
|
Pediatr Infect Dis J
|
2009
|
0.83
|
|
140
|
Familial hemophagocytic lymphohistiocytosis: a model for understanding the human machinery of cellular cytotoxicity.
|
Cell Mol Life Sci
|
2011
|
0.83
|
|
141
|
Structure of the human NK cell triggering receptor NKp46 ectodomain.
|
Biochem Biophys Res Commun
|
2003
|
0.83
|
|
142
|
Structure of the Ly49 family of natural killer (NK) cell receptors and their interaction with MHC class I molecules.
|
Immunol Res
|
2004
|
0.83
|
|
143
|
NKp44 expression, phylogenesis and function in non-human primate NK cells.
|
Int Immunol
|
2009
|
0.82
|
|
144
|
In vivo generation of decidual natural killer cells from resident hematopoietic progenitors.
|
Haematologica
|
2013
|
0.81
|
|
145
|
TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells.
|
Eur J Immunol
|
2014
|
0.81
|
|
146
|
The management of paediatric allergy: not everybody's cup of tea--10-11th February 2012.
|
Curr Opin Allergy Clin Immunol
|
2013
|
0.81
|
|
147
|
Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells.
|
Eur J Immunol
|
2003
|
0.80
|
|
148
|
How melanoma cells inactivate NK cells.
|
Oncoimmunology
|
2012
|
0.80
|
|
149
|
Interactions between mesenchymal stem cells and dendritic cells.
|
Adv Biochem Eng Biotechnol
|
2013
|
0.80
|
|
150
|
Lymphocyte effector mechanisms in innate and adaptive immunity.
|
Curr Opin Immunol
|
2005
|
0.80
|
|
151
|
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30.
|
Exp Hematol
|
2009
|
0.80
|
|
152
|
XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
|
Eur J Immunol
|
2014
|
0.79
|
|
153
|
Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines.
|
Eur J Immunol
|
2015
|
0.79
|
|
154
|
Structure of the saccharide-binding domain of the human natural killer cell inhibitory receptor p75/AIRM1.
|
Acta Crystallogr D Biol Crystallogr
|
2004
|
0.79
|
|
155
|
Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.
|
Int Immunol
|
2009
|
0.79
|
|
156
|
Selective preservation of bone marrow mature recirculating but not marginal zone B cells in murine models of chronic inflammation.
|
PLoS One
|
2010
|
0.79
|
|
157
|
IFN-alpha-mediated increase in cytolytic activity of maturing NK cell upon exposure to HSV-infected myelomonocytes.
|
Eur J Immunol
|
2009
|
0.78
|
|
158
|
NK cells from malignant pleural effusions are potent antitumor effectors: A clue for adoptive immunotherapy?
|
Oncoimmunology
|
2013
|
0.78
|
|
159
|
Receptor modulation and functional activation of human CD34+ Lin- -derived immature NK cells in vitro by Mycobacterium bovis Bacillus Calmette-Guerin (BCG).
|
Eur J Immunol
|
2012
|
0.78
|
|
160
|
Entropically assisted carbohydrate recognition by a natural killer cell-surface receptor.
|
Chembiochem
|
2004
|
0.78
|
|
161
|
Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation.
|
Best Pract Res Clin Haematol
|
2011
|
0.78
|
|
162
|
Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts.
|
J Transl Med
|
2014
|
0.78
|
|
163
|
Expression, crystallization and preliminary crystallographic analysis of the extracellular IgV-like domain of the human natural killer cell inhibitory receptor p75/AIRM1.
|
Acta Crystallogr D Biol Crystallogr
|
2003
|
0.76
|
|
164
|
Transplantation and innate immunity: the lesson of natural killer cells.
|
Ital J Pediatr
|
2009
|
0.76
|
|
165
|
Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus.
|
J Transl Med
|
2015
|
0.76
|
|
166
|
Understanding human NK cell differentiation: clues for improving the haploidentical hematopoietic stem cell transplantation.
|
Immunol Lett
|
2013
|
0.75
|
|
167
|
Natural killer cells in healthy and diseased subjects.
|
J Biomed Biotechnol
|
2011
|
0.75
|
|
168
|
Foreword. New frontiers in molecular and cellular therapy.
|
Immunol Lett
|
2013
|
0.75
|
|
169
|
Expression and crystallographic characterization of the extracellular domain of human natural killer cell triggering receptor NKp46.
|
Acta Crystallogr D Biol Crystallogr
|
2003
|
0.75
|
|
170
|
Revisited function of human NK cell subsets.
|
Cell Cycle
|
2011
|
0.75
|
|
171
|
Unsung hero Robert C. Gallo.
|
Science
|
2009
|
0.75
|
|
172
|
Crystallization and preliminary crystallographic characterization of the extracellular Ig-like domain of human natural killer cell activating receptor NKp44.
|
Acta Crystallogr D Biol Crystallogr
|
2002
|
0.75
|